Please use this identifier to cite or link to this item:
https://doi.org/10.18632/oncotarget.5512
DC Field | Value | |
---|---|---|
dc.title | HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma | |
dc.contributor.author | Xue, Y | |
dc.contributor.author | Toh, S.Y | |
dc.contributor.author | He, P | |
dc.contributor.author | Lim, T | |
dc.contributor.author | Lim, D | |
dc.contributor.author | Pang, C.L | |
dc.contributor.author | Abastado, J.-P | |
dc.contributor.author | Thierry, F | |
dc.date.accessioned | 2020-10-27T05:45:16Z | |
dc.date.available | 2020-10-27T05:45:16Z | |
dc.date.issued | 2015 | |
dc.identifier.citation | Xue, Y, Toh, S.Y, He, P, Lim, T, Lim, D, Pang, C.L, Abastado, J.-P, Thierry, F (2015). HPV16-E2 induces prophase arrest and activates the cellular DNA damage response in vitro and in precursor lesions of cervical carcinoma. Oncotarget 6 (33) : 34979-34991. ScholarBank@NUS Repository. https://doi.org/10.18632/oncotarget.5512 | |
dc.identifier.issn | 19492553 | |
dc.identifier.uri | https://scholarbank.nus.edu.sg/handle/10635/180931 | |
dc.description.abstract | Cervical intraepithelial neoplasia (CIN) is caused by human papillomavirus (HPV) infection and is the precursor to cervical carcinoma. The completion of the HPV productive life cycle depends on the expression of viral proteins which further determines the severity of the cervical neoplasia. Initiation of the viral productive replication requires expression of the E2 viral protein that cooperates with the E1 viral DNA helicase. A decrease in the viral DNA replication ability and increase in the severity of cervical neoplasia is accompanied by simultaneous elevated expression of E6 and E7 oncoproteins. Here we reveal a novel and important role for the HPV16-E2 protein in controlling host cell cycle during malignant transformation. We showed that cells expressing HPV16-E2 in vitro are arrested in prophase alongside activation of a sustained DDR signal. We uncovered evidence that HPV16-E2 protein is present in vivo in cells that express both mitotic and DDR signals specifically in CIN3 lesions, immediate precursors of cancer, suggesting that E2 may be one of the drivers of genomic instability and carcinogenesis in vivo. | |
dc.rights | Attribution 4.0 International | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.source | Unpaywall 20201031 | |
dc.subject | DNA | |
dc.subject | unclassified drug | |
dc.subject | virus E2 protein | |
dc.subject | virus protein | |
dc.subject | DNA binding protein | |
dc.subject | E2 protein, Human papillomavirus type 16 | |
dc.subject | oncoprotein | |
dc.subject | Article | |
dc.subject | cell cycle arrest | |
dc.subject | cell cycle regulation | |
dc.subject | controlled study | |
dc.subject | DNA damage | |
dc.subject | DNA repair | |
dc.subject | female | |
dc.subject | genomic instability | |
dc.subject | human | |
dc.subject | human cell | |
dc.subject | Human papillomavirus type 16 | |
dc.subject | human tissue | |
dc.subject | in vitro study | |
dc.subject | in vivo study | |
dc.subject | major clinical study | |
dc.subject | malignant transformation | |
dc.subject | nonhuman | |
dc.subject | prophase | |
dc.subject | protein expression | |
dc.subject | uterine cervix carcinoma in situ | |
dc.subject | virus carcinogenesis | |
dc.subject | virus cell interaction | |
dc.subject | cell cycle checkpoint | |
dc.subject | cell transformation | |
dc.subject | complication | |
dc.subject | flow cytometry | |
dc.subject | fluorescent antibody technique | |
dc.subject | immunohistochemistry | |
dc.subject | immunoprecipitation | |
dc.subject | in situ hybridization | |
dc.subject | metabolism | |
dc.subject | papillomavirus infection | |
dc.subject | pathology | |
dc.subject | physiology | |
dc.subject | precancer | |
dc.subject | prophase | |
dc.subject | uterine cervix carcinoma in situ | |
dc.subject | uterine cervix tumor | |
dc.subject | virology | |
dc.subject | Western blotting | |
dc.subject | Blotting, Western | |
dc.subject | Cell Cycle Checkpoints | |
dc.subject | Cell Transformation, Neoplastic | |
dc.subject | Cervical Intraepithelial Neoplasia | |
dc.subject | DNA Damage | |
dc.subject | DNA-Binding Proteins | |
dc.subject | Female | |
dc.subject | Flow Cytometry | |
dc.subject | Fluorescent Antibody Technique | |
dc.subject | Humans | |
dc.subject | Immunohistochemistry | |
dc.subject | Immunoprecipitation | |
dc.subject | In Situ Hybridization | |
dc.subject | Oncogene Proteins, Viral | |
dc.subject | Papillomavirus Infections | |
dc.subject | Precancerous Conditions | |
dc.subject | Prophase | |
dc.subject | Uterine Cervical Neoplasms | |
dc.type | Article | |
dc.contributor.department | PATHOLOGY | |
dc.description.doi | 10.18632/oncotarget.5512 | |
dc.description.sourcetitle | Oncotarget | |
dc.description.volume | 6 | |
dc.description.issue | 33 | |
dc.description.page | 34979-34991 | |
Appears in Collections: | Staff Publications Elements |
Show simple item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_18632_oncotarget_5512.pdf | 9.07 MB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License